Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Revelation Biosciences Selects Avance Clinical As Cro For Phase 2/3 Titan Study

BRIEF-Revelation Biosciences Selects Avance Clinical As Cro For Phase 2/3 Titan Study

ReutersReuters2026/08/19 13:01
By:Reuters

Revelation Biosciences Inc REVB.O:

  • REVELATION BIOSCIENCES SELECTS AVANCE CLINICAL AS CRO FOR PHASE 2/3 TITAN STUDY

  • REVELATION BIOSCIENCES - PHASE 2/3 TITAN STUDY EXPECTED TO BEGIN LATER THIS YEAR

Source text: ID:nBw53q34La

Further company coverage: REVB.O


0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!